Literature DB >> 25428648

Cytokine production associated with smallpox vaccine responses.

Whitney L Simon1, Hannah M Salk, Inna G Ovsyannikova, Richard B Kennedy, Gregory A Poland.   

Abstract

Smallpox was eradicated 34 years ago due to the success of the smallpox vaccine; yet, the vaccine continues to be studied because of its importance in responding to potential biological warfare and the adverse events associated with current smallpox vaccines. Interindividual variations in vaccine response are observed and are, in part, due to genetic variation. In some cases, these varying responses lead to adverse events, which occur at a relatively high rate for the smallpox vaccine compared with other vaccines. Here, we aim to summarize the cytokine responses associated with smallpox vaccine response to date. Along with a description of each of these cytokines, we describe the genetic and adverse event data associated with cytokine responses to smallpox vaccination.

Entities:  

Keywords:  cellular immunity; cytokines; humoral immunity; smallpox vaccine; vaccines; vaccinia virus

Mesh:

Substances:

Year:  2014        PMID: 25428648      PMCID: PMC4263415          DOI: 10.2217/imt.14.72

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  100 in total

1.  Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2013-06-24       Impact factor: 2.850

Review 2.  Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

Authors:  K Nakanishi; T Yoshimoto; H Tsutsui; H Okamura
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

3.  The immunogenetics of smallpox vaccination.

Authors:  Samuel L Stanley; Sharon E Frey; Patricia Taillon-Miller; Jianhua Guo; Raymond D Miller; Daniel C Koboldt; Michael Elashoff; Ryan Christensen; Nancy L Saccone; Robert B Belshe
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

4.  Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis.

Authors:  J R Lane; D A Neumann; A Lafond-Walker; A Herskowitz; N R Rose
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

5.  Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Gene       Date:  2012-08-23       Impact factor: 3.688

6.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication.

Authors:  N Harris; R M Buller; G Karupiah
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Frequency of adverse events after vaccination with different vaccinia strains.

Authors:  Mirjam Kretzschmar; Jacco Wallinga; Peter Teunis; Shuqin Xing; Rafael Mikolajczyk
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

9.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  7 in total

1.  Integrative representations and analyses of vaccine-induced intended protective immunity and unintended adverse events using ontology-based and theory-guided approaches.

Authors:  Yongqun He; Edison Ong; Jiangan Xie
Journal:  Glob Vaccines Immunol       Date:  2016-05-23

2.  Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response.

Authors:  Jean-Louis Palgen; Nicolas Tchitchek; Jamila Elhmouzi-Younes; Simon Delandre; Inana Namet; Pierre Rosenbaum; Nathalie Dereuddre-Bosquet; Frédéric Martinon; Antonio Cosma; Yves Lévy; Roger Le Grand; Anne-Sophie Beignon
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

3.  Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants.

Authors:  Brittany A Moser; Yoseline Escalante-Buendia; Rachel C Steinhardt; Matthew G Rosenberger; Britteny J Cassaidy; Nihesh Naorem; Alfred C Chon; Minh H Nguyen; Ngoctran T Tran; Aaron P Esser-Kahn
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

4.  Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease.

Authors:  Thomas M Aune; John T Tossberg; Rachel M Heinrich; Krislyn P Porter; Philip S Crooke
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

Review 5.  Defending against smallpox: a focus on vaccines.

Authors:  Emily A Voigt; Richard B Kennedy; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2016-04-28       Impact factor: 5.217

6.  Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination.

Authors:  Kawsar R Talaat; Neal A Halsey; Amber B Cox; Christian L Coles; Anna P Durbin; Amritha Ramakrishnan; Jay H Bream
Journal:  Influenza Other Respir Viruses       Date:  2018-01-04       Impact factor: 4.380

7.  Evaluating the Alimentary and Respiratory Tracts in Health and disease (EARTH) research programme: a protocol for prospective, longitudinal, controlled, observational studies in children with chronic disease at an Australian tertiary paediatric hospital.

Authors:  Michael J Coffey; Isabelle R McKay; Michael Doumit; Sandra Chuang; Susan Adams; Sacha Stelzer-Braid; Shafagh A Waters; Nadine A Kasparian; Torsten Thomas; Adam Jaffe; Tamarah Katz; Chee Y Ooi
Journal:  BMJ Open       Date:  2020-04-14       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.